Cipla to acquire stake in therapeutics startup Wellthy

  • Ltd has agreed to acquire an 11.71 % stake in health-tech startup Therapeutics Pvt.
  • By pairing our pharmacotherapy strengths with the digital approach to healthcare taken by Wellthy Therapeutics, Cipla will add to its diversified portfolio in the cardio-metabolic area to provide holistic care to patients from awareness, diagnosis and compliance to wellbeing,” said Umang Vohra, managing director and global CEO at Cipla.
  • The drugmaker also said that, under the agreement, a multi-lingual clinically validated digital disease management platform will be made available to patients living with diabetes or cardiovascular diseases via doctors’ clinics or co-packaging on select Cipla brands.

What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

JBM acquires majority stake in Germany’s Linde-Wiemann

International brand 7-Eleven to enter Indian retail market